Key points are not available for this paper at this time.
The identification of benign and malignant pulmonary nodules (BPN and MPN) can significantly reduce mortality. However, a reliable and validated diagnostic model for clinical decision-making is still lacking.
Chen et al. (Fri,) studied this question.